202 related articles for article (PubMed ID: 36856111)
1. CRISPR/Cas9 screen uncovers functional translation of cryptic lncRNA-encoded open reading frames in human cancer.
Zheng C; Wei Y; Zhang P; Xu L; Zhang Z; Lin K; Hou J; Lv X; Ding Y; Chiu Y; Jain A; Islam N; Malovannaya A; Wu Y; Ding F; Xu H; Sun M; Chen X; Chen Y
J Clin Invest; 2023 Mar; 133(5):. PubMed ID: 36856111
[TBL] [Abstract][Full Text] [Related]
2. Cryptic lncRNA-encoded ORFs: A hidden source of regulatory proteins.
Dutta A; Li H; Abounader R
J Clin Invest; 2023 Mar; 133(5):. PubMed ID: 36856112
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9-based functional interrogation of unconventional translatome reveals human cancer dependency on cryptic non-canonical open reading frames.
Zheng C; Wei Y; Zhang P; Lin K; He D; Teng H; Manyam G; Zhang Z; Liu W; Lee HRL; Tang X; He W; Islam N; Jain A; Chiu Y; Cao S; Diao Y; Meyer-Gauen S; Höök M; Malovannaya A; Li W; Hu M; Wang W; Xu H; Kopetz S; Chen Y
Nat Struct Mol Biol; 2023 Dec; 30(12):1878-1892. PubMed ID: 37932451
[TBL] [Abstract][Full Text] [Related]
4. Estrogen distinctly regulates transcription and translation of lncRNAs and pseudogenes in breast cancer cells.
Choo SW; Zhong Y; Sendler E; Goustin AS; Cai J; Ju D; Kosir MA; Giordo R; Lipovich L
Genomics; 2022 Jul; 114(4):110421. PubMed ID: 35779786
[TBL] [Abstract][Full Text] [Related]
5. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
[TBL] [Abstract][Full Text] [Related]
7. LncRNA-mediated regulation of
Tariq A; Hao Q; Sun Q; Singh DK; Jadaliha M; Zhang Y; Chetlangia N; Ma J; Holton SE; Bhargava R; Lal A; Prasanth SG; Prasanth KV
RNA; 2020 Feb; 26(2):175-185. PubMed ID: 31690584
[TBL] [Abstract][Full Text] [Related]
8. Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer Research.
Zhen S; Li X
Hum Gene Ther; 2019 Jan; 30(1):3-9. PubMed ID: 30045635
[TBL] [Abstract][Full Text] [Related]
9.
Fang Z; Wang Y; Wang Z; Xu M; Ren S; Yang D; Hong M; Xie W
Cancer Res; 2020 Oct; 80(20):4399-4413. PubMed ID: 32826278
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-induced circRNA, circPGR, functions as a ceRNA to promote estrogen receptor-positive breast cancer cell growth by regulating cell cycle-related genes.
Wang L; Yi J; Lu LY; Zhang YY; Wang L; Hu GS; Liu YC; Ding JC; Shen HF; Zhao FQ; Huang HH; Liu W
Theranostics; 2021; 11(4):1732-1752. PubMed ID: 33408778
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
13. H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis.
Xie N; Zhang R; Bi Z; Ren W; You K; Hu H; Xu Y; Yao H
Cell Oncol (Dordr); 2023 Apr; 46(2):375-390. PubMed ID: 36576700
[TBL] [Abstract][Full Text] [Related]
14. A hidden translatome in tumors-the coding lncRNAs.
Wang J; Wang W; Ma F; Qian H
Sci China Life Sci; 2023 Dec; 66(12):2755-2772. PubMed ID: 37154857
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-Inducible LncRNA
Horie K; Takagi K; Takeiwa T; Mitobe Y; Kawabata H; Suzuki T; Ikeda K; Inoue S
Cells; 2022 Nov; 11(22):. PubMed ID: 36429038
[TBL] [Abstract][Full Text] [Related]
16. Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer.
Peng WX; Huang JG; Yang L; Gong AH; Mo YY
Mol Cancer; 2017 Oct; 16(1):161. PubMed ID: 29041978
[TBL] [Abstract][Full Text] [Related]
17. Single-Molecule Sequencing Reveals Estrogen-Regulated Clinically Relevant lncRNAs in Breast Cancer.
Jonsson P; Coarfa C; Mesmar F; Raz T; Rajapakshe K; Thompson JF; Gunaratne PH; Williams C
Mol Endocrinol; 2015 Nov; 29(11):1634-45. PubMed ID: 26426411
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs differential expression in breast cancer subtypes: What do we know?
Mathias C; Zambalde EP; Rask P; Gradia DF; de Oliveira JC
Clin Genet; 2019 May; 95(5):558-568. PubMed ID: 30614523
[TBL] [Abstract][Full Text] [Related]
19. Expression profiles and functional prediction of long non-coding RNAs LINC01133, ZEB1-AS1 and ABHD11-AS1 in the luminal subtype of breast cancer.
Mehrpour Layeghi S; Arabpour M; Shakoori A; Naghizadeh MM; Mansoori Y; Tavakkoly Bazzaz J; Esmaeili R
J Transl Med; 2021 Aug; 19(1):364. PubMed ID: 34446052
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
